Trial no.:
|
PACTR201709002647413 |
Date of Approval:
|
18/07/2018 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Pecto-intercostal fascial block vs Pecc block |
Official scientific title |
The analgesic efficacy of Pecto-intercostal fascial block in combination with pectoral nerve block in patients undergoing modified radical mastectomy |
Brief summary describing the background
and objectives of the trial
|
Breast czancer is the most common cancer among women and most of them require breast surgery. Acute postoperative pain is an important risk factor for the development of persistent chronic postoperative pain after breast surgery. Therefore, effective postoperative pain management after breast cancer surgery is necessary. Systemic opioids can be administered using patient-controlled devices but the analgesic effect can be limited and un-desirable side effects may occur. Several forms of regional techniques like local anesthetic infiltration, intercostal nerve block, epidural block and PVB have been used for management of pain after breast surgery. Pectoral nerve block (Pecs) block is an ultrasound guided inter-fascial plane block that targets tissue planes between the pectoralis major and minor (Pecs I0, and the pectoralis minor and serratus anterior muscles (Pecs II). Single injection Pecs block have shown excellent efficacy for analgesia after breast surgery. However, Pecs block do not block the anterior branches of the intercostal nerves or the entire nipple-areolar complex. Pecto-intercostal fascial block (PIFB) targets the anterior cutaneous branch of the intercostal nerve. PIFB may be beneficial for the analgesic management of surgical procedures of the thorax and breast surgery. The aim of the study will be the evaluation and comparison of the analgesic efficacy of the combines PIFB and Pecs block with that of the Pecs block alone in patients undergoing unilateral modified radical mastectomy (RM) |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Cancer,postoperative pain after unilateral modified radical mastectomy,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
01/10/2017 |
Actual trial start date |
|
Anticipated date of last follow up |
01/04/2018 |
Actual Last follow-up date |
27/08/2018 |
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Completed |
Publication URL |
|
|